AstraZeneca is a world-renowned pharmaceutical company with a factory in Taizhou.
According to public information, AstraZeneca plans to increase its capital in Taizhou production and supply base, and consider building a new diabetes drug production line including Andaz (generic name: daparizine metformin sustained-release tablets). By further expanding its production capacity, it will continue to build Taizhou into a global production base for AstraZeneca diabetes products.